Stay updated on Nivolumab in Advanced Lung Cancer: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced Lung Cancer: Clinical Trial page.

Latest updates to the Nivolumab in Advanced Lung Cancer: Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.4.3 and no longer displays Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status with a link to cc.nih.gov and opm.gov. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe changes are minor UI and wording updates: the glossary is now shown, and several small label and version-text updates (including capitalization of 'Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0') were made; no study content or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page's revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations were updated: new site locations across multiple states and Canadian provinces were added, and several existing locations were removed.SummaryDifference2%

Stay in the know with updates to Nivolumab in Advanced Lung Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Lung Cancer: Clinical Trial page.